150 related articles for article (PubMed ID: 32342992)
1. Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification.
Press RH; Shafer SL; Jiang R; Buchwald ZS; Abugideiri M; Tian S; Morgan TM; Behera M; Sengupta S; Voloschin AD; Olson JJ; Hasan S; Blumenthal DT; Curran WJ; Eaton BR; Shu HG; Zhong J
Cancer; 2020 Jul; 126(14):3255-3264. PubMed ID: 32342992
[TBL] [Abstract][Full Text] [Related]
2. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.
Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY
Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053
[TBL] [Abstract][Full Text] [Related]
3. Optimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database.
Buszek SM; Al Feghali KA; Elhalawani H; Chevli N; Allen PK; Chung C
Sci Rep; 2020 Mar; 10(1):4926. PubMed ID: 32188907
[TBL] [Abstract][Full Text] [Related]
4. Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?
Nakamura H; Murakami R; Hirai T; Kitajima M; Yamashita Y
Acta Radiol; 2013 Mar; 54(2):214-20. PubMed ID: 23138021
[TBL] [Abstract][Full Text] [Related]
5. The impact of timing of adjuvant therapy on survival for patients with glioblastoma: An analysis of the National Cancer Database.
Amsbaugh MJ; Yusuf M; Gaskins J; Burton E; Woo S
J Clin Neurosci; 2019 Aug; 66():92-99. PubMed ID: 31104962
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Care and Outcomes of Hypofractionated Chemoradiation Versus Conventionally Fractionated Chemoradiation for Glioblastoma in the Elderly Population.
Haque W; Verma V; Butler EB; Teh BS
Am J Clin Oncol; 2018 Feb; 41(2):167-172. PubMed ID: 29369825
[TBL] [Abstract][Full Text] [Related]
7. Patterns of care and outcomes for glioblastoma in patients with poor performance status.
Malakhov N; Lee A; Garay E; Becker DJ; Schreiber D
J Clin Neurosci; 2018 Jun; 52():66-70. PubMed ID: 29576419
[TBL] [Abstract][Full Text] [Related]
8. Impact of Timing of Adjuvant Chemoradiation for Glioblastoma in a Large Hospital Database.
Osborn VW; Lee A; Garay E; Safdieh J; Schreiber D
Neurosurgery; 2018 Nov; 83(5):915-921. PubMed ID: 29092047
[TBL] [Abstract][Full Text] [Related]
9. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
Wen J; Chen W; Zhu Y; Zhang P
BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
[TBL] [Abstract][Full Text] [Related]
10. Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients.
Pichlmeier U; Bink A; Schackert G; Stummer W;
Neuro Oncol; 2008 Dec; 10(6):1025-34. PubMed ID: 18667747
[TBL] [Abstract][Full Text] [Related]
11. The survival impact of significant delays between surgery and radiochemotherapy in glioblastoma patients: A retrospective analysis from a large tertiary center.
Magrowski Ł; Nowicka E; Masri O; Tukiendorf A; Tarnawski R; Miszczyk M
J Clin Neurosci; 2021 Aug; 90():39-47. PubMed ID: 34275579
[TBL] [Abstract][Full Text] [Related]
12. Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.
Sun MZ; Oh T; Ivan ME; Clark AJ; Safaee M; Sayegh ET; Kaur G; Parsa AT; Bloch O
J Neurosurg; 2015 May; 122(5):1144-50. PubMed ID: 25768833
[TBL] [Abstract][Full Text] [Related]
13. Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme.
Seidlitz A; Siepmann T; Löck S; Juratli T; Baumann M; Krause M
Radiat Oncol; 2015 Aug; 10():172. PubMed ID: 26276734
[TBL] [Abstract][Full Text] [Related]
14. Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme.
Kole AJ; Park HS; Yeboa DN; Rutter CE; Corso CD; Aneja S; Lester-Coll NH; Mancini BR; Knisely JP; Yu JB
Cancer; 2016 Aug; 122(15):2364-70. PubMed ID: 27172136
[TBL] [Abstract][Full Text] [Related]
15. A Comparative Analysis of the Usefulness of Survival Prediction Models for Patients with Glioblastoma in the Temozolomide Era: The Importance of Methylguanine Methyltransferase Promoter Methylation, Extent of Resection, and Subventricular Zone Location.
Woo P; Ho J; Lam S; Ma E; Chan D; Wong WK; Mak C; Lee M; Wong ST; Chan KY; Poon WS
World Neurosurg; 2018 Jul; 115():e375-e385. PubMed ID: 29678708
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and Patterns of Care in Elderly Patients with Glioblastoma Multiforme.
Nunna RS; Khalid SI; Patel S; Sethi A; Behbahani M; Mehta AI; Adogwa O; Byrne RW
World Neurosurg; 2021 May; 149():e1026-e1037. PubMed ID: 33482415
[TBL] [Abstract][Full Text] [Related]
17. Survival impact of the time gap between surgery and chemo-radiotherapy in Glioblastoma patients.
Zur I; Tzuk-Shina T; Guriel M; Eran A; Kaidar-Person O
Sci Rep; 2020 Jun; 10(1):9595. PubMed ID: 32533126
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic meningioma: an analysis of the National Cancer Database from 2004 to 2012.
Orton A; Frandsen J; Jensen R; Shrieve DC; Suneja G
J Neurosurg; 2018 Jun; 128(6):1684-1689. PubMed ID: 28731397
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
20. Delaying standard combined chemoradiotherapy after surgical resection does not impact survival in newly diagnosed glioblastoma patients.
Louvel G; Metellus P; Noel G; Peeters S; Guyotat J; Duntze J; Le Reste PJ; Dam Hieu P; Faillot T; Litre F; Desse N; Petit A; Emery E; Voirin J; Peltier J; Caire F; Vignes JR; Barat JL; Langlois O; Menei P; Dumont SN; Zanello M; Dezamis E; Dhermain F; Pallud J;
Radiother Oncol; 2016 Jan; 118(1):9-15. PubMed ID: 26791930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
